Reply
- PMID: 38403431
- DOI: 10.1002/art.42836
Reply
References
-
- Lu Q, Yao Z, Gan Y, et al. A diagnostic performance study of the 2023 American College of Rheumatology/EULAR classification criteria for patients with antiphospholipid syndrome from the Antiphospholipid Syndrome Chinese Collaborative cohort presenting with suspected antiphospholipid syndrome. Arthritis Rheumatol Published online February 25, 2024. doi:https://doi.org/10.1002/art.42835
-
- Barbhaiya M, Zuily S, Naden R, et al. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 2023;75:1687–1702.
-
- Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis 2023;82:1258–1270.
-
- Tang Z, Shi H, Liu HL, et al. Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria.’ Ann Rheum Dis 2024;83:e4.
-
- Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 2006;4:295–306.
Publication types
LinkOut - more resources
Full Text Sources